SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-058840
Filing Date
2023-11-03
Accepted
2023-11-03 16:15:22
Documents
13
Period of Report
2023-11-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-20231102.htm   iXBRL 8-K 48606
2 EX-4.1 apvo-ex4_1.htm EX-4.1 36359
  Complete submission text file 0000950170-23-058840.txt   209486

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apvo-20231102_pre.xml EX-101.PRE 10302
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apvo-20231102.xsd EX-101.SCH 2487
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apvo-20231102_lab.xml EX-101.LAB 14028
7 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20231102_htm.xml XML 4925
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 231376510
SIC: 2834 Pharmaceutical Preparations